New science is the engine of progress. Airfinity is the tool to unlock the future.
Featured in more than 200 newspapers, journals and on TV networks worldwide
Access Covid-19 data you can trust today.
Get immediate answers to your critical C-19 questions with access to Airfinity’s platform - a comprehensive real time data source and analytics engine relied upon by governments, medical organisations, top hedgefunds, pharmaceuticals and researchers worldwide.
When will a working vaccine be widely available?
When will lockdown restrictions ease in specific countries?
Which vaccines and treatments show most promise?
Where are the major risks in global supply and production capacity?
What are the real time insights derived from the scientific data and opinions of experts?
Book a demo
Featured insights and interviews
On the historic day where the UK administered its first dose of COVID-19 vaccines, our CEO Rasmus Bech Hansen is on BBC News at 10 pm to explain the production challenges that lie ahead and share Airfinity's latest immunisation forecasts.
Airfinity's macro forecast for 2021 shows wide discrepancy in when countries can expect to go back to normal. CEO Rasmus Bech Hansen talks about global vaccine availability and production forecasts for 2021 on Bloomberg TV.
Airfinity CEO Rasmus Bech Hansen is interviewed live on Bloomberg TV to discusses recent COVID-19 vaccine results, the time line of roll outs and wider scientific ramifications.
With all eyes on the vaccine race and Pfizer the current front runner, Rasmus Bech Hansen (Airfinity CEO) discusses with Julia Chatterley whether standards have been compromised for speed.
We collect data from the earliest sources which allows us to provide our clients with the most up-to-date comprehensive and granular intelligence on critical new scientific developments in real-time.
By turning millions of fragmented science-related data points into a structured data set we build predictive, compound-centric meta-analysis and forecasts for trial readouts, approval likelihood, production, pricing and more.
Our therapy area structure mirrors the scientific community and ensures you have all the information you need in one place. We cover research, supply chains, regulation, disease developments, funding etc. from sources in more than 50 languages.
All information is classified and analysed by specialised experts ensuring the highest standards and quality. Our analyst team consist of some of the most talented scientist of their generation, top KOLs and industry veterans.
A proprietary set of scientific impact metrics allows for an objective data-driven picture of the scientific consensus within a therapy area. We are fiercely independent and data driven in our analysis.